Inventor · disambiguated record
Jose Enrique Montero Casimiro
Also filed as: MONTERO CASIMIRO JOSE ENRIQUE · MONTERO CASIMIRO JOSÉ ENRIQUE
7 granted patents·5 pending applications·21 citations·filing 2002–2021
80Inventor score
Files withBIOCON LTD5MONTERO CASIMIRO JOSE ENRIQUE3CENTRO DE IMMUNOLOGIA MOLECULAR1CENTRO INMUNOLOGIA MOLECULAR1CT DE INMUNOLGIA MOLECULAR1
Top patents by PatentIndex Score
12 records- 0186US11028168B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2018·Granted Jun 8, 2021·3 cites·8 claims
- 0279US9856502B2Methods for controlling fucosylation levels in proteinsBIOCON LTD·Filed 2014·Granted Jan 2, 2018·6 cites·5 claims
- 0377US8435521B2Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of B-chronic lymphocytic leukaemiaMONTERO CASIMIRO JOSE ENRIQUE·Filed 2007·Granted May 7, 2013·9 cites·5 claims
- 0473US10189899B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2014·Granted Jan 29, 2019·2 cites·6 claims
- 0565US8563003B2Method for the treatment of malignant and infectious chronic diseasesMONTERO CASIMIRO JOSE ENRIQUE·Filed 2002·Granted Oct 22, 2013·1 cites·47 claims
- 0665US2022025038A1Use of a cd6 binding partner and method based thereonBIOCON LTD·Filed 2021·Application pending·0 cites
- 0751US10308970B2Methods for controlling fucosylation levels in proteinsBIOCON LTD·Filed 2017·Granted Jun 4, 2019·0 cites·5 claims
- 0851US2010092423A1Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritisCT DE INMUNOLGIA MOLECULAR·Filed 2007·Application pending·0 cites
- 0950US2016024220A1Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritisCENTRO INMUNOLOGIA MOLECULAR·Filed 2014·Application pending·0 cites
- 1044US2017066835A1Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritisCT INMUNOLOGIA MOLECULAR·Filed 2016·Application pending·0 cites
- 1133US2009274647A1Immunotherapeutic Formulations with Interleukin-2-Neutralizing CapacityMONTERO CASIMIRO JOSE ENRIQUE·Filed 2005·Application pending·0 cites
- 1230US9790279B2Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)CENTRO DE IMMUNOLOGIA MOLECULAR·Filed 2012·Granted Oct 17, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Jose Enrique Montero Casimiro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →